发布求助
文献互助 智能选刊 最新文献

Annals of Medical and Clinical Oncology最新文献

筛选
英文 中文
Metastatic Prostate Cancers at the University Hospital Center-Bogodogo (CHU-B) in OUAGADOUGOU : Situation in a Resource-Limited Country like Burkina Faso 瓦加杜古博戈多大学医院中心（CHU-B）的转移性前列腺癌：布基纳法索这样一个资源有限国家的情况
Annals of Medical and Clinical Oncology Pub Date : 2023-11-16 DOI: 10.29011/2833-3497.000157
{"title":"Metastatic Prostate Cancers at the University Hospital Center-Bogodogo (CHU-B) in OUAGADOUGOU : Situation in a Resource-Limited Country like Burkina Faso","authors":"","doi":"10.29011/2833-3497.000157","DOIUrl":"https://doi.org/10.29011/2833-3497.000157","url":null,"abstract":"","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"286 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139268602","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Peripheral Neuropathies in Checkpoint Inhibitor Therapy: An In-depth Investigation through Pharmacovigilance Data-driven Analysis 检查点抑制剂治疗中的周围神经病变:通过药物警戒数据驱动分析的深入研究
Annals of Medical and Clinical Oncology Pub Date : 2023-08-28 DOI: 10.29011/2833-3497.000153
Tenorio Phm, LZ Freitas, OJ Nascimento, Osvaldo José Moreira do Nascimento
{"title":"Peripheral Neuropathies in Checkpoint Inhibitor Therapy: An In-depth Investigation through Pharmacovigilance Data-driven Analysis","authors":"Tenorio Phm, LZ Freitas, OJ Nascimento, Osvaldo José Moreira do Nascimento","doi":"10.29011/2833-3497.000153","DOIUrl":"https://doi.org/10.29011/2833-3497.000153","url":null,"abstract":"Background: In recent years, the advent of immunotherapeutic drugs, particularly checkpoint inhibitors (CIs), has revolutionized the landscape of cancer treatment, offering unprecedented hope and improved outcomes for patients. Given the increasing use of these immunotherapies, in addition to the impact on patient survival and quality of life, it is necessary to better understand adverse events related to CIs. Objective: search and analyze data contained in an important pharmacovigilance database (FAERS), in order to understand the incidence of peripheral neuropathies, as an adverse event, in patients undergoing therapy with CIs in a real-world context. Methods: This observational study analyzes post-marketing pharmacovigilance data on CIs, The study focuses on adverse events within the (FAERS) database and IQVIA Analytics databases","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130232793","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possible Lurbinectedin-associated Cardiotoxicity in a Patient with Metastatic Small Cell Lung Cancer: A Case Report 转移性小细胞肺癌患者可能与lurbinectedin相关的心脏毒性:1例报告
Annals of Medical and Clinical Oncology Pub Date : 2023-07-21 DOI: 10.29011/28333497.000152
Ilerhunmwuwa Nosakhare Paul, Hakobyan Narek, A. Henry, Wasifuddin Mustafa, Abowali Hesham, B. Avezbakiyev
{"title":"Possible Lurbinectedin-associated Cardiotoxicity in a Patient with Metastatic Small Cell Lung Cancer: A Case Report","authors":"Ilerhunmwuwa Nosakhare Paul, Hakobyan Narek, A. Henry, Wasifuddin Mustafa, Abowali Hesham, B. Avezbakiyev","doi":"10.29011/28333497.000152","DOIUrl":"https://doi.org/10.29011/28333497.000152","url":null,"abstract":"Background: It has been a major challenge finding an effective second-line therapy with a favorable safety profile for metastatic small cell lung cancer (SCLC) in patients who failed or relapsed following first-line platinum-based chemotherapy. Lurbinectedin was approved for SCLC in patients who relapsed or failed first-line treatment. The most common adverse event associated with it was myelosuppression. Till date, no cardiotoxicity has been described with this medication in the literature.","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124159608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Zoledronic Acid-Induced Lesions Mimicking Metastasis in Patients with Bone Cancers 唑来膦酸诱导的骨癌病变模拟转移
Annals of Medical and Clinical Oncology Pub Date : 2023-07-10 DOI: 10.29011/2833-3497.000151
L. Olsen, Madeline Link, P. Kent
{"title":"Zoledronic Acid-Induced Lesions Mimicking Metastasis in Patients with Bone Cancers","authors":"L. Olsen, Madeline Link, P. Kent","doi":"10.29011/2833-3497.000151","DOIUrl":"https://doi.org/10.29011/2833-3497.000151","url":null,"abstract":"Zoledronic acid (ZA) is used to treat osteoporosis, hypercalcemia, metabolic bone disease, cancer induced bone disease, and Paget’s disease of bone. In cancer patients with bone metastasis, it can decrease pain and occasionally induce shrinkage. For primary bone tumors, such as osteosarcoma and Ewing sarcoma, zoledronic acid has been trialed as part of combination chemotherapy strategy in high-risk patients. Osteonecrosis of the jaw is a well described side effect of ZA, but osteonecrosis of other bones is very rare. We describe three patients with relapsed primary bone tumors on zoledronic acid who had presumed relapse with new bony metastasis, that was subsequently contradicted by alternative imaging and biopsy. We hypothesize that these false positive results were due to zoledronic acid inhibiting the cycle of tumor cell proliferation and bone resorption causing bony infarcts in a tumor dependent pathway that increases osteoblast activity. We hope that awareness of this rare phenomenon will encourage practitioners to prove bone metastasis in primary bone cancers by biopsy, or alternative imaging before concluding current therapy has failed.","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115459797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Frequency Modulated RF Waves for Treating Cancers and Tumors 调频射频波在癌症和肿瘤治疗中的应用
Annals of Medical and Clinical Oncology Pub Date : 2023-03-02 DOI: 10.29011/2833-3497.000147
{"title":"Application of Frequency Modulated RF Waves for Treating Cancers and Tumors","authors":"","doi":"10.29011/2833-3497.000147","DOIUrl":"https://doi.org/10.29011/2833-3497.000147","url":null,"abstract":"","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"33 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133852176","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deferred Nephrectomy after a Surprising Response to Immunotherapy in Poor Risk Patients: A Case Report 低风险患者免疫治疗后延迟肾切除术的惊人反应:一例报告
Annals of Medical and Clinical Oncology Pub Date : 2023-02-23 DOI: 10.29011/2833-3497.000146
{"title":"Deferred Nephrectomy after a Surprising Response to Immunotherapy in Poor Risk Patients: A Case Report","authors":"","doi":"10.29011/2833-3497.000146","DOIUrl":"https://doi.org/10.29011/2833-3497.000146","url":null,"abstract":"","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"21 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132579193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differential Expression of Necroptosis-Related Genes with regulating lncRNA in Triple Negative Breast Cancer to Predict Prognosis and Immunotherapy Response 三阴性乳腺癌中坏死相关基因与lncRNA的差异表达预测预后和免疫治疗反应
Annals of Medical and Clinical Oncology Pub Date : 2023-02-10 DOI: 10.29011/2833-3497.000144
Zijun Zhao, Xiayao Diao, Qing Cao, X. Lu
{"title":"Differential Expression of Necroptosis-Related Genes with regulating lncRNA in Triple Negative Breast Cancer to Predict Prognosis and Immunotherapy Response","authors":"Zijun Zhao, Xiayao Diao, Qing Cao, X. Lu","doi":"10.29011/2833-3497.000144","DOIUrl":"https://doi.org/10.29011/2833-3497.000144","url":null,"abstract":"Differential Expression of Necroptosis-Related","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"377 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122658139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential Biomarkers in Drug-Resistant Colorectal Cancer Cells 结直肠癌耐药细胞中的潜在生物标志物
Annals of Medical and Clinical Oncology Pub Date : 2022-12-19 DOI: 10.29011/2833-3497.000142
{"title":"Potential Biomarkers in Drug-Resistant Colorectal Cancer Cells","authors":"","doi":"10.29011/2833-3497.000142","DOIUrl":"https://doi.org/10.29011/2833-3497.000142","url":null,"abstract":"","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"37 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"125411226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What Makes a Cancer Team Successful? 是什么让癌症团队成功?
Annals of Medical and Clinical Oncology Pub Date : 2022-09-26 DOI: 10.29011/2833-3497.000140
{"title":"What Makes a Cancer Team Successful?","authors":"","doi":"10.29011/2833-3497.000140","DOIUrl":"https://doi.org/10.29011/2833-3497.000140","url":null,"abstract":"","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130930133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Glypican 3 (GPC 3) In Cancer Pathogenesis and Progression Glypican 3 (gpc3)在癌症发病和进展中的作用
Annals of Medical and Clinical Oncology Pub Date : 2022-07-14 DOI: 10.29011/amco-130.000138
{"title":"Glypican 3 (GPC 3) In Cancer Pathogenesis and Progression","authors":"","doi":"10.29011/amco-130.000138","DOIUrl":"https://doi.org/10.29011/amco-130.000138","url":null,"abstract":"","PeriodicalId":254574,"journal":{"name":"Annals of Medical and Clinical Oncology","volume":"32 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"126546531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信